Autoantibodies Against Oxidatively Modified LDL Do Not Constitute a Risk Factor for Stroke | Zendy

Ejaz Ahmed | Zendy; Jasmina Trifunovic | Zendy; Birgitta Stegmayr | Zendy; Göran Hallmans | Zendy; Ann Kari Lefvert | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Autoantibodies Against Oxidatively Modified LDL Do Not Constitute a Risk Factor for Stroke

Author(s) -

Ejaz Ahmed,

Jasmina Trifunovic,

Birgitta Stegmayr,

Göran Hallmans,

Ann Kari Lefvert

Publication year - 1999

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/01.str.30.12.2541

Subject(s) - medicine , autoantibody , stroke (engine) , diabetes mellitus , risk factor , population , prospective cohort study , antibody , vascular disease , gastroenterology , endocrinology , immunology , mechanical engineering , environmental health , engineering

Autoantibodies against oxidatively modified LDL have been shown to be associated with atherosclerosis. Their possible pathogenic role is not yet fully understood, and earlier published data are inconsistent. In this prospective study, we have investigated the association of these antibodies with future stroke.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research